Cargando…

Metabolic acidosis and the progression of chronic kidney disease

Metabolic acidosis is a common complication of chronic kidney disease. Accumulating evidence identifies acidosis not only as a consequence of, but as a contributor to, kidney disease progression. Several mechanistic pathways have been identified in this regard. The dietary acid load, even in the abs...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Abramowitz, Matthew K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233646/
https://www.ncbi.nlm.nih.gov/pubmed/24708763
http://dx.doi.org/10.1186/1471-2369-15-55
_version_ 1782344760648794112
author Chen, Wei
Abramowitz, Matthew K
author_facet Chen, Wei
Abramowitz, Matthew K
author_sort Chen, Wei
collection PubMed
description Metabolic acidosis is a common complication of chronic kidney disease. Accumulating evidence identifies acidosis not only as a consequence of, but as a contributor to, kidney disease progression. Several mechanistic pathways have been identified in this regard. The dietary acid load, even in the absence of overt acidosis, may have deleterious effects. Several small trials now suggest that the treatment of acidosis with oral alkali can slow the progression of kidney disease.
format Online
Article
Text
id pubmed-4233646
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42336462014-11-18 Metabolic acidosis and the progression of chronic kidney disease Chen, Wei Abramowitz, Matthew K BMC Nephrol Review Metabolic acidosis is a common complication of chronic kidney disease. Accumulating evidence identifies acidosis not only as a consequence of, but as a contributor to, kidney disease progression. Several mechanistic pathways have been identified in this regard. The dietary acid load, even in the absence of overt acidosis, may have deleterious effects. Several small trials now suggest that the treatment of acidosis with oral alkali can slow the progression of kidney disease. BioMed Central 2014-04-03 /pmc/articles/PMC4233646/ /pubmed/24708763 http://dx.doi.org/10.1186/1471-2369-15-55 Text en Copyright © 2014 Chen and Abramowitz; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Chen, Wei
Abramowitz, Matthew K
Metabolic acidosis and the progression of chronic kidney disease
title Metabolic acidosis and the progression of chronic kidney disease
title_full Metabolic acidosis and the progression of chronic kidney disease
title_fullStr Metabolic acidosis and the progression of chronic kidney disease
title_full_unstemmed Metabolic acidosis and the progression of chronic kidney disease
title_short Metabolic acidosis and the progression of chronic kidney disease
title_sort metabolic acidosis and the progression of chronic kidney disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233646/
https://www.ncbi.nlm.nih.gov/pubmed/24708763
http://dx.doi.org/10.1186/1471-2369-15-55
work_keys_str_mv AT chenwei metabolicacidosisandtheprogressionofchronickidneydisease
AT abramowitzmatthewk metabolicacidosisandtheprogressionofchronickidneydisease